Impact of Adalimumab Therapy On Laboratory Parameters of Interest in Patients with Early or Long-Standing Rheumatoid Arthritis

被引：0
|
作者：
Furst, De [1 ]
Lacerda, Ana P. [2 ]
Andhivarothai, Nupun [3 ]
Kalabic, Jasmina [4 ]
Mozaffarian, Neelufar [3 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Abbott Labs, Sao Paulo, Brazil
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Abbott GmbH & Co KG, Ludwigshafen, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
486
引用
收藏
页码：S211 / S212
页数：2
相关论文
共 50 条
  • [1] ROUTINE PREVENTATIVE VACCINATIONS IN PATIENTS WITH LONG-STANDING RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB
    Mozaffarian, N.
    Liu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 602 - 602
  • [2] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH EARLY AND LONG-STANDING RHEUMATOID ARTHRITIS
    Kanonirova, M. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A85 - A86
  • [3] Safety of adalimumab (HUMIRA®) in global clinical trials of patients with early vs. long-standing rheumatoid arthritis (RA)
    Schiff, MH
    Burmester, GR
    Pangan, AL
    Kupper, H
    Spencer-Green, GT
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 422 - +
  • [4] Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis
    Han, Chenglong
    Smolen, Josef
    Kavanaugh, Arthur
    Clair, E. William St.
    Baker, Daniel
    Bala, Mohan
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (04): : 510 - 514
  • [5] Effects of adalimumab monotherapy on health utility and fatigue in patients with long-standing, severe rheumatoid arthritis (RA)
    Mittendorf, T
    Sterz, R
    Greiner, W
    Von der Schulenburg, J
    Cifaldi, M
    Dietz, B
    VALUE IN HEALTH, 2005, 8 (03) : 342 - 342
  • [6] Adalimumab (HUMIRA®) plus methotrexate induces sustained remission in both early and long-standing rheumatoid arthritis.
    Emery, P
    Schiff, MH
    Kalden, JR
    Spencer-Green, GT
    Segurado, OG
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S183 - S184
  • [7] Adalimumab inhibits radiographic disease progression in long-standing, rapidly progressive rheumatoid arthritis
    Rau, R
    Herborn, G
    de Putte, LBV
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 191 - 191
  • [8] Aggressive therapy in patients with stable, long-standing rheumatoid arthritis—does it make a difference?
    Aaron T Eggebeen
    Mary Chester M Wasko
    Nature Clinical Practice Rheumatology, 2006, 2 : 530 - 531
  • [9] Achieving Comprehensive Disease Control in Long-Standing or Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate versus Methotrexate Alone
    Keystone, Edward
    Breedveld, Ferdinand
    Van der Heijde, Desiree
    Van Vollenhoven, Ronald
    Florentinus, Stefan
    Faccin, Freddy
    Liu, Shufang
    Kupper, Hartmut
    Kavanaugh, Arthur
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 996 - 996
  • [10] Achieving Comprehensive Disease Control in Long-Standing or Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate Versus Methotrexate Alone
    Keystone, Edward C.
    Breedveld, Ferdinand C.
    van der Heijde, Desiree
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Faccin, Freddy
    Liu, Shufang
    Kupper, Hartmut
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S559 - S559
12345